Chemotherapy_of_metastatic_and/or_recurrent_undifferentiated_nasopharyngeal_carcinoma_with_cisplatin,_bleomycin,_and_fluorouracil._Undifferentiated_nasopharyngeal_carcinoma_(UCNT)_is_known_to_be_radiosensitive_and_chemosensitive,_but_the_latter_has_never_been_studied_prospectively_with_phase_II_methodology._After_an_intensive_work-up,_49_patients_with_recurrent_(REC)_and/or_metastatic_(MTS)_UCNT_were_treated_with_three_monthly_cycles_of_cisplatin_(CDDP)_100_mg/m2_day_1;_bleomycin_15_mg_intravenously_(IV)_day_1,_and_16_mg/m2/d_continuous_infusion_(CI)_days_1_to_5;_and_fluorouracil_(5FU)_650_mg/m2/d_CI_days_1_to_5_(PBF)._Of_the_49_patients,_33_were_North_African._The_sex_ratio_was_three_males:one_female,_and_the_median_World_Health_Organization_(WHO)_performance_status_was_1.6._In_the_48_patients_assessable_for_response,_we_observed_nine_(19%)_complete_responses_(CRs)_and_29_(60%)_partial_responses_(PRs)_(60%),_for_a_79%_overall_response_rate_(95%_confidence_interval,_68%_to_90%)_in_the_assessable_group_and_a_78%_global_rate._There_were_eight_CRs_(24%)_observed_in_the_group_without_previous_chemotherapy_(33_patients)_compared_with_one_CR_in_the_chemotherapy_pretreated_group_(16_patients)._Four_patients_are_still_alive_without_evidence_of_disease_after_52+,_54+,_58+,_and_58+_months,_respectively._All_of_them_had_less_than_three_bone_MTS_sites,_and_received_radiation_therapy_in_these_sites._The_results_confirm_the_chemosensitivity_of_UCNT,_and_the_observation_of_unmaintained_long-term_responders_makes_curability_a_possible_consideration.